| PERIOD ENDING | 31-Dec-05 | 31-Dec-04 | 31-Dec-02 |
| Total Revenue | 3,649 | 305 | 182 |
| Cost of Revenue | 2,341 | 106 | 136 |
|
| Gross Profit | 1,309 | 199 | 46 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 1,749 | 421 | 181 |
| Non Recurring |
-
|
-
|
-
|
| Others | 85 |
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (525) | (221) | (135) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (525) | (221) | (135) |
| Interest Expense |
-
| 73 | 74 |
| Income Before Tax | (525) | (295) | (209) |
| Income Tax Expense | (210) |
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (315) | (295) | (209) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (315) | (295) | (209) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($315) | ($295) | ($209) |
0.20% Nasdaq 
Income Statement
